Drug-Coated Balloon (DCB)
Peripheral Arterial Disease (PAD)
Pre-clinicalActive
Key Facts
About Arterius
Arterius is a private, pre-revenue medical device company developing next-generation, patient-centric solutions for arterial disease, primarily peripheral arterial disease (PAD). The company has built two synergistic polymer technology platforms: a drug-coated balloon (DCB) coating for efficient single or dual-drug transfer to the vessel wall, and the ArterioSorb™ bioresorbable scaffold, a fully resorbable stent designed to provide temporary support. Founded in 2015 and based in Leeds, UK, Arterius has raised over £10 million in grants and equity, achieved ISO 13485 certification, and is planning First-in-Human studies for its lead products.
View full company profileTherapeutic Areas
Other Peripheral Arterial Disease (PAD) Drugs
| Drug | Company | Phase |
|---|---|---|
| ArterioSorb™ Bioresorbable Scaffold | Arterius | Pre-clinical |
| ETR-based Graft | Xeltis | Pre-clinical |
| ATEV | Humacyte | Phase 2/3 |